Cereblon and IRF4 Variants Affect Risk and Response to Treatment in Multiple Myeloma
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1661-4917
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Cereblon and IRF4 Variants Affect Risk and Response to Treatment in Multiple Myeloma ; day:12 ; month:1 ; year:2017 ; pages:1-6
Archivum immunologiae et therapiae experimentalis ; (12.1.2017), 1-6
- Keyword
-
Krebs
Onkologie
- Creator
-
Butrym, Aleksandra
- Contributor
-
Łacina, Piotr
Rybka, Justyna
Chaszczewska-Markowska, Monika
Mazur, Grzegorz
Bogunia-Kubik, Katarzyna
SpringerLink (Online service)
- DOI
-
10.1007/s00005-016-0442-6
- URN
-
urn:nbn:de:1111-201702109795
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:54 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Butrym, Aleksandra
- Łacina, Piotr
- Rybka, Justyna
- Chaszczewska-Markowska, Monika
- Mazur, Grzegorz
- Bogunia-Kubik, Katarzyna
- SpringerLink (Online service)
Other Objects (12)
Characterization of rare germline variants in familial multiple myeloma
Multiple myeloma and physical activity
Investigation of rare non-coding variants in familial multiple myeloma
Multiple myeloma
Telomere length and hTERT genetic variants as potential prognostic markers in multiple myeloma
Components of metabolic syndrome in patients with multiple myeloma and smoldering multiple myeloma
Exome sequencing identifies germline variants in DIS3 in familial multiple myeloma
P01.15. Multiple Myeloma, chemotherapy and curcumin
Emerging agents and regimens for multiple myeloma
Multiple Myeloma: Molecular Pathogenesis and Disease Evolution
Multiple myeloma: signaling pathways and targeted therapy
RNA sequencing identifies novel regulated IRE1-dependent decay targets that affect multiple myeloma survival and proliferation
Characterization of rare germline variants in familial multiple myeloma
Multiple myeloma and physical activity
Investigation of rare non-coding variants in familial multiple myeloma
Multiple myeloma
Telomere length and hTERT genetic variants as potential prognostic markers in multiple myeloma
Components of metabolic syndrome in patients with multiple myeloma and smoldering multiple myeloma
Exome sequencing identifies germline variants in DIS3 in familial multiple myeloma
P01.15. Multiple Myeloma, chemotherapy and curcumin
Emerging agents and regimens for multiple myeloma
Multiple Myeloma: Molecular Pathogenesis and Disease Evolution
Multiple myeloma: signaling pathways and targeted therapy
RNA sequencing identifies novel regulated IRE1-dependent decay targets that affect multiple myeloma survival and proliferation
Characterization of rare germline variants in familial multiple myeloma
Multiple myeloma and physical activity
Investigation of rare non-coding variants in familial multiple myeloma
Multiple myeloma
Telomere length and hTERT genetic variants as potential prognostic markers in multiple myeloma
Components of metabolic syndrome in patients with multiple myeloma and smoldering multiple myeloma
Exome sequencing identifies germline variants in DIS3 in familial multiple myeloma
P01.15. Multiple Myeloma, chemotherapy and curcumin
Emerging agents and regimens for multiple myeloma
Multiple Myeloma: Molecular Pathogenesis and Disease Evolution
Multiple myeloma: signaling pathways and targeted therapy